LeMaitre VascularSTU:LHU +3.21%97 OCF Margin % is 22.68% as of Mar. 2026, which is 16% above its 10-year median of 19.53. GuruFocus rates STU:LHU with a GF Score™ of 97/100 and a GF Value™ of €84.74 (Fairly Valued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, LeMaitre Vascular ranks better than 94.97% on this metric.
The historical rank and industry rank for LeMaitre Vascular's OCF Margin % or its related term are showing as below:
STU:LHU'
s OCF Margin % Range Over the Past 10 Years
Min: 12.09 Med: 19.53 Max: 32.55
Current: 34.01
During the past 13 years, the highest OCF Margin % of LeMaitre Vascular was 32.55%. The lowest was 12.09%. And the median was 19.53%.
STU:LHU's OCF Margin % is ranked better than 94.97% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs STU:LHU: 34.01
LeMaitre Vascular OCF Margin % Related Terms
LeMaitre Vascular OCF Margin % Historical Data
* Premium members only.
The historical data trend for LeMaitre Vascular's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:LHU vs XRAY, PLSE, NNNN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's OCF Margin % distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular (STU:LHU) has a OCF Margin % of 22.68% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on LeMaitre Vascular and its competitors. This is 16% above median its historical median of 19.53. Over the past decade, LeMaitre Vascular's OCF Margin % has ranged from 12.09 to 32.55. According to the industry distribution chart, LeMaitre Vascular ranks #41 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 5%.
Is LeMaitre Vascular's OCF Margin % too high?
LeMaitre Vascular's current OCF Margin % of 22.68% is 16% above median its 10-year median of 19.53. Over the past 10 years, this metric has ranged from a low of 12.09 to a high of 32.55. The Medical Devices & Instruments industry median OCF Margin % is 5.86. LeMaitre Vascular's value of 22.68% is 287% above this industry median. Based on the distribution chart, LeMaitre Vascular ranks #41 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LeMaitre Vascular has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's OCF Margin % compare to XRAY and PLSE?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #41 out of 815 companies for OCF Margin %. This places LeMaitre Vascular in the top 5% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. LeMaitre Vascular's value of 22.68% is 287% above this benchmark. Historically, LeMaitre Vascular's own OCF Margin % has ranged from 12.09 to 32.55 over the past decade. While the company's 10-year median is 19.53 vs. the industry median of 5.86, LeMaitre Vascular has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LeMaitre Vascular's current OCF Margin % of 22.68% is 287% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on LeMaitre Vascular and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeMaitre Vascular's current OCF Margin % is 22.68%, which is 16% above median its own 10-year median of 19.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (STU:LHU) is currently considered Fairly Valued. The stock's GF Value™ is €84.74, compared to a current price of €80.50 — trading 5% below its estimated fair value. The current OCF Margin % is 22.68%, which is 16% above median its 10-year median of 19.53 and 287% above the Medical Devices & Instruments industry median of 5.86. LeMaitre Vascular's overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For LeMaitre Vascular (STU:LHU), the current OCF Margin % is 22.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LeMaitre Vascular (STU:LHU) Overvalued in 2026?
Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued.
The current stock price of €80.50 is trading 5% below its estimated GF Value™ of €84.74.
GuruFocus considers LeMaitre Vascular to be Fairly Valued.
Key valuation signals for STU:LHU:
OCF Margin %: 22.68% (16% above median its 10-year median of 19.53)
GF Value™: €84.74 vs. price of €80.50 (5% below fair value)
Industry Position: 287% above the Medical Devices & Instruments median (#41 of 815)
No single metric tells the full story. See the STU:LHU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
97GF Score
Get the complete analysis for STU:LHU
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:LHU has been successfully added to your 
